Trial · NCT03330119
Determining the Effect of an "Alternate Recovery Protocol" Versus Current Standard of Care After Cesarean Section
NCT03330119, Phase 3, Terminated, Brest, Norman A., M.D.; results first posted 2021-03-02
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Determining the Effect of an "Alternate Recovery Protocol" Versus Current Standard of Care After Cesarean Section. Trials, record NCT03330119. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03330119
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Determining the Effect of an "Alternate Recovery Protocol" Versus Current Standard of Care After Cesarean Section
- NCT number
- NCT03330119
- Status
- Terminated
- Phases
- Phase 3
- Enrollment
- 1,494 participants, actual
- Lead sponsor
- Brest, Norman A., M.D.
- Conditions
- Pregnancy Related, Narcotic Use
- Interventions
- Alternate Management, Control
- First posted
- 2017-11-06
- Last updated
- 2021-03-02
- Results first posted
- 2021-03-02
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Narcotic Utilization | From time of consent until hospital discharge (3 days) | total narcotic utilization measured with Morphine Milligram Equivalent (MME) The conversion scale being used will be the Center for Disease Control and Prevention Morphine Equivalent Score. Lower scores represent less opioid use and a better outcome. Higher scores represent more opioid use and a worse outcome. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Narcotic Utilization | From time of consent until hospital discharge (3 days) | MME | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Narcotic Utilization | Alternate Management | 33.3 | Standard Deviation 52.4 | MME | |
| Narcotic Utilization | Control | 47.2 | Standard Deviation 60.4 | MME |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Alternate Management | 641 | |
| Overall Study | STARTED | Control | 853 | |
| Overall Study | COMPLETED | Alternate Management | 475 | |
| Overall Study | COMPLETED | Control | 571 | |
| Overall Study | NOT COMPLETED | Alternate Management | 166 | |
| Overall Study | NOT COMPLETED | Control | 282 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Alternate Management | 0 | 475 |
| Total, all-cause mortality | Control | 0 | 641 |
| Total, other adverse events | Alternate Management | 0 | 475 |
| Total, other adverse events | Control | 0 | 641 |
| Total, serious adverse events | Alternate Management | 0 | 475 |
| Total, serious adverse events | Control | 0 | 641 |
Source ClinicalTrials.gov
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Alternate Management vs Control: deaths from any cause | Trial comparisons |
| Alternate Management vs Control: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03330119
GET https://conductscience.org/api/trials/v1/NCT03330119/registered